Clinical Trials
17 trialsNCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT07252570 2025-11-26
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
Centre Hospitalier Universitaire de Nice
Completed
NCT06265272 2025-09-26
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
Recruiting
NCT06773260 2025-01-22
ELASTO-HCC
Azienda Ospedaliero Universitaria Policlinico Modena
Enrolling by invitation
NCT06434753 2024-06-04
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Recruiting
NCT05703750 2023-05-31
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
Zhongda Hospital
Unknown
NCT05704192 2023-05-31
CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
Zhongda Hospital
Unknown
NCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT05141617 2021-12-02
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT01642446 2021-09-27
Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension
Sun Yat-sen University
Phase NA Completed
NCT04994548 2021-08-06
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension
Central Hospital, Nancy, France
Completed
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT04524650 2020-08-28
Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Unknown
NCT04524676 2020-08-24
Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT02145013 2018-02-12
Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma
Henri Mondor University Hospital
Unknown
NCT02305914 2015-05-22
FSCAP
The First Affiliated Hospital of Nanchang University
Unknown
NCT00280007 2010-04-22
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma
Medical University of Vienna
Phase 2 Terminated